Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03834948
What this trial is testing

AO-176 in Multiple Solid Tumor Malignancies

Who this might be right for
Solid Tumor
Arch Oncology 57
Not applicableUnknownNCT05077358
What this trial is testing

Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection

Who this might be right for
Adenocarcinoma of the Colon
Yonsei University 241
Not applicableStudy completedNCT03135925
What this trial is testing

Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation

Who this might be right for
Myeloma
Sheffield Teaching Hospitals NHS Foundation Trust 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT05610332
What this trial is testing

Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

Who this might be right for
Locally Advanced Gastric Cancer
Fujian Medical University 216
Testing effectiveness (Phase 2)Study completedNCT03439293
What this trial is testing

Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
Takeda 61
Large-scale testing (Phase 3)Study completedNCT00293514
What this trial is testing

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Who this might be right for
Pulmonary DiseasesIntraoperative Complications
Nycomed
Testing effectiveness (Phase 2)UnknownNCT03940833
What this trial is testing

Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM

Who this might be right for
Multiple Myeloma
Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00866138
What this trial is testing

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Who this might be right for
Multiple Myeloma
AB Science 24
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Not applicableEnrolling By InvitationNCT06729736
What this trial is testing

Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study

Who this might be right for
Colorectal Cancer
Seoul National University Hospital 500
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Not applicableUnknownNCT03490084
What this trial is testing

Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 300
Not applicableActive Not RecruitingNCT06323447
What this trial is testing

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Who this might be right for
Diffuse Large B Cell LymphomaMultiple Myeloma
Leuko Labs, Inc. 210
Testing effectiveness (Phase 2)Study completedNCT00110058
What this trial is testing

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT06516926
What this trial is testing

SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Who this might be right for
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 11
Testing effectiveness (Phase 2)Ended earlyNCT04294784
What this trial is testing

Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Huazhong University of Science and Technology 58
Next Page